"The Great Plains Health Callahan Cancer Center is an advanced, one-stop cancer center designed with patient care and convenience in mind. With 15 cancer treatment rooms, an on-site pharmacist and comprehensive cancer services all in the same location, our goal is to make cancer treatment as comfortable and seamless as possible for the patients we serve."

During the past decade, Great Plains Health Callahan Cancer Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 38 clinical trials were completed, i.e. on average, 152% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 18 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Great Plains Health Callahan Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "American Society of Clinical Oncology" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Great Plains Health Callahan Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Great Plains Health Callahan Cancer Center" are "Breast Cancer" (4 trials), "Clear Cell Renal Cell Carcinoma" (4 trials), "Stage III Renal Cell Cancer AJCC v7" (4 trials), "Stage IV Renal Cell Cancer AJCC v7" (4 trials) and "Recurrent Breast Carcinoma" (3 trials). Many other conditions were trialed in "Great Plains Health Callahan Cancer Center" in a lesser frequency.

Most popular intervention types in "Great Plains Health Callahan Cancer Center" are "Drug" (55 trials), "Other" (45 trials), "Biological" (25 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Quality-of-Life Assessment" (10 trials), "Bevacizumab" (9 trials), "Cisplatin" (9 trials) and "Nivolumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Great Plains Health Callahan Cancer Center" are 54 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Great Plains Health Callahan Cancer Center". undefined are not yet recruiting, 9 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Great Plains Health Callahan Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Great Plains Health Callahan Cancer Center, 3 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".